{"columns": ["cmem_t_edit_distance", "cmem_t_is_updated", "cmem_t_memory_len", "cmem_t_memory_str", "cmem_t_memory_str_len"], "data": [[NaN, NaN, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [100.0, true, 4.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin", 189.0], [86.0, true, 5.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor", 251.0], [100.0, true, 5.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor", 251.0], [78.0, false, 5.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor", 251.0], [86.0, true, 6.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nInvasive lobular carcinoma is considered T2 if it is greater than 2 cm in size", 330.0], [89.0, true, 7.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nInvasive lobular carcinoma is considered T2 if it is greater than 2 cm in size\nFor staging, only the size of the largest focus of the invasive tumor is considered", 414.0], [46.0, false, 7.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nInvasive lobular carcinoma is considered T2 if it is greater than 2 cm in size\nFor staging, only the size of the largest focus of the invasive tumor is considered", 414.0], [89.0, true, 8.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nInvasive lobular carcinoma is considered T2 if it is greater than 2 cm in size\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating ductal carcinoma, T stage is determined based on the size of the tumor", 514.0], [87.0, true, 9.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nInvasive lobular carcinoma is considered T2 if it is greater than 2 cm in size\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating ductal carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)", 670.0], [96.0, true, 10.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nInvasive lobular carcinoma is considered T2 if it is greater than 2 cm in size\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating ductal carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size", 730.0], [93.0, true, 11.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nInvasive lobular carcinoma is considered T2 if it is greater than 2 cm in size\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating ductal carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 844.0], [91.0, true, 11.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating ductal carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nT1c tumors are greater than 1 cm but not more than 2 cm in size", 829.0], [96.0, true, 10.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating ductal carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 765.0], [93.0, true, 11.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating lobular carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status", 870.0], [93.0, true, 12.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating lobular carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status", 1007.0], [95.0, true, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating lobular carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern", 1104.0], [94.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating lobular carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast", 1243.0], [97.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating lobular carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component", 1328.0], [91.0, true, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nIf the tumor is infiltrating lobular carcinoma, T stage is determined based on the size of the tumor\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nThe T stage is assigned based on the size of the tumor, with T1 indicating 2 cm or less, T2 indicating more than 2 cm but not more than 5 cm, T3 indicating more than 5 cm, and T4 indicating tumor of any size with direct extension to the chest wall or skin.", 1585.0], [95.0, true, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nThe T stage is assigned based on the size of the tumor, with T1 indicating 2 cm or less, T2 indicating more than 2 cm but not more than 5 cm, T3 indicating more than 5 cm, and T4 indicating tumor of any size with direct extension to the chest wall or skin.\nTumor grade is not a factor in determining T stage", 1535.0], [97.0, true, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nThe T stage is assigned based on the size of the tumor, with T1 indicating 2 cm or less, T2 indicating more than 2 cm but not more than 5 cm, T3 indicating more than 5 cm, and T4 indicating tumor of any size with direct extension to the chest wall or skin.\nTumor grade is not a factor in determining T stage\nTumor size for T stage is based on the invasive component, not the in situ component", 1641.0], [95.0, true, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nThe T stage is assigned based on the size of the tumor, with T1 indicating 2 cm or less, T2 indicating more than 2 cm but not more than 5 cm, T3 indicating more than 5 cm, and T4 indicating tumor of any size with direct extension to the chest wall or skin.\nTumor grade is not a factor in determining T stage\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 1695.0], [55.0, false, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nThe T stage is assigned based on the size of the tumor, with T1 indicating 2 cm or less, T2 indicating more than 2 cm but not more than 5 cm, T3 indicating more than 5 cm, and T4 indicating tumor of any size with direct extension to the chest wall or skin.\nTumor grade is not a factor in determining T stage\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 1695.0], [87.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 1302.0], [97.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor grade and receptor status do not affect T stage determination", 1370.0], [64.0, false, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor grade and receptor status do not affect T stage determination", 1370.0], [91.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination", 1256.0], [98.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT2 tumors are more than 2 cm but not more than 5 cm in size", 1316.0], [95.0, true, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the main determinant of T stage, with no additional considerations for tumor type or margin status in this case", 1442.0], [97.0, true, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nT1 tumors are 2 cm or less in size, and are further divided into T1a (less than 0.5 cm), T1b (0.5-1 cm), and T1c (greater than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT2 tumors are more than 2 cm but not more than 5 cm in size\nTumor size is the main determinant of T stage, with no additional considerations for tumor type or margin status in this case\nT4 tumors are of any size with direct extension to the chest wall or skin", 1516.0], [84.0, true, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination", 1100.0], [93.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [96.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 1380.0], [96.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [64.0, false, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [73.0, false, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [78.0, false, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)", 1266.0], [95.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast", 1410.0], [96.0, true, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nThe T stage is determined based on the size of the largest focus of the invasive tumor, regardless of the tumor grade or receptor status\nInfiltrating lobular carcinomas are staged based on tumor size, regardless of the growth pattern\nThe T stage is based solely on the size of the tumor, and does not take into account the number of tumors or their locations in the breast\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 1524.0], [80.0, true, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component", 1151.0], [72.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component", 1151.0], [95.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component", 1281.0], [96.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status", 1395.0], [98.0, true, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size greater than 5 cm is classified as T3", 1444.0], [97.0, true, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nThe T stage is not affected by immunohistochemistry results such as e-cadherin, ER, PgR, or HER2 status\nTumor grade and receptor status do not affect T stage determination\nT1 tumors are further divided into T1a (less than or equal to 0.5 cm), T1b (more than 0.5 cm but not more than 1 cm), and T1c (more than 1 cm but not more than 2 cm)\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size greater than 5 cm is classified as T3\nDirect extension of the tumor to the chest wall or skin results in a T4 stage", 1522.0], [85.0, true, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nDirect extension of the tumor to the chest wall or skin results in a T4 stage", 1135.0], [91.0, true, 11.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component", 943.0], [93.0, true, 12.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present", 1088.0], [97.0, true, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage", 1157.0], [95.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component", 1271.0], [95.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status", 1414.0], [59.0, false, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nFor staging, only the size of the largest focus of the invasive tumor is considered\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status", 1414.0], [92.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status, and not the size of the in situ component", 1487.0], [95.0, true, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status, and not the size of the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion", 1643.0], [59.0, false, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status, and not the size of the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion", 1643.0], [95.0, true, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status, and not the size of the in situ component\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1816.0], [83.0, true, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1659.0], [67.0, false, 16.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1659.0], [95.0, true, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion", 1844.0], [4.0, false, 17.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, not the size of other invasive carcinomas if multiple are present\nSubstaging information is not considered for determining the T stage\nThe T stage is based on the size of the invasive tumor and not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion", 1844.0], [84.0, true, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [60.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [60.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [60.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [60.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [60.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [97.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nIf the tumor size is more than 2 cm but not more than 5 cm, the T stage is T2", 1409.0], [38.0, false, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nIf the tumor size is more than 2 cm but not more than 5 cm, the T stage is T2", 1409.0], [58.0, false, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nIf the tumor size is more than 2 cm but not more than 5 cm, the T stage is T2", 1409.0], [97.0, true, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [60.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [5.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [60.0, false, 13.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size", 1331.0], [95.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and lymphovascular invasion", 1471.0], [97.0, true, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and lymphovascular invasion\nTumor size should be measured in the largest focus of the invasive tumor, not the in situ component", 1571.0], [5.0, false, 15.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and lymphovascular invasion\nTumor size should be measured in the largest focus of the invasive tumor, not the in situ component", 1571.0], [88.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and lymphovascular invasion\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size should be measured in the largest focus of the invasive tumor, not the in situ component", 1457.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and lymphovascular invasion\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size should be measured in the largest focus of the invasive tumor, not the in situ component", 1457.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and lymphovascular invasion\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size should be measured in the largest focus of the invasive tumor, not the in situ component", 1457.0], [100.0, true, 14.0, "T1: Tumor size is 2 cm or less\nT2: Tumor size is more than 2 cm but not more than 5 cm\nT3: Tumor size is more than 5 cm\nT4: Tumor of any size with direct extension to the chest wall or skin\nT stage is determined based on the size of the largest focus of the invasive tumor\nTumor size is the primary determinant of T stage, with additional considerations for tumor type and margin status\nTumor size for T stage is based on the largest focus of the invasive tumor, regardless of the number of tumors or their locations in the breast\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and lymphovascular invasion\nTumor size for T stage is based on the invasive component, not the in situ component\nTumor size in T stage is based on the largest focus of the invasive tumor, not the size of the ductal carcinoma in situ component\nTumor size for T stage is based on the size of the largest invasive carcinoma, with additional considerations for tumor type and margin status\nTumor size is the primary determinant of T stage, with additional considerations for tumor type, margin status, and the presence of lymphovascular invasion\nThe T stage is based on the size of the invasive tumor and does not take into account the presence of in situ carcinoma or lymphovascular invasion when determining the size\nTumor size should be measured in the largest focus of the invasive tumor, not the in situ component", 1457.0]]}